Planet 13 Holdings (PLNH) Operating Leases (2021 - 2026)
Planet 13 Holdings (PLNH) posted quarterly Operating Leases of $42.9 million for Q1 2026, down 10.47% year-over-year from $47.9 million in Q1 2025, and down 3.83% quarter-over-quarter from $44.6 million in Q4 2025.
Planet 13 Holdings (PLNH) Operating Leases (2021 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has reported Operating Leases for 6 consecutive years, with $42.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Leases fell 10.47% year-over-year to $42.9 million; the TTM figure through Mar 2026 stood at $42.9 million (down 10.47% YoY), while the FY2025 annual figure was $44.6 million, down 3.98% from the prior year.
- Operating Leases fell to $42.9 million in Q1 2026 per PLNH's latest filing, from $44.6 million in the prior quarter.
- Across five years, Operating Leases topped out at $48.2 million in Q3 2025 and bottomed at $25.3 million in Q4 2023.
- Historically, Operating Leases has averaged $35.6 million across 5 years, with a median of $26.7 million in 2023.
- Annual changes were most pronounced in 2024 — Operating Leases soared 83.8% — and 2026, when it decreased 10.47%.
- Planet 13 Holdings' Operating Leases stood at $26.3 million in 2022, then retreated by 3.95% to $25.3 million in 2023, then jumped by 83.8% to $46.4 million in 2024, then slipped by 3.98% to $44.6 million in 2025, then dropped by 3.83% to $42.9 million in 2026.
- Business Quant data shows PLNH's Operating Leases at $42.9 million in Q1 2026, $44.6 million in Q4 2025, and $48.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Planet 13 Holdings | 50.16 Mn | 33.68 Mn | 12.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 44.15 Mn |
| Mar 31, 2026 | 42.89 Mn |
| Dec 31, 2025 | 44.60 Mn |
| Sep 30, 2025 | 48.20 Mn |
| Jun 30, 2025 | 48.07 Mn |
| Mar 31, 2025 | 47.90 Mn |
| Dec 31, 2024 | 46.45 Mn |
| Sep 30, 2024 | 45.70 Mn |
| Jun 30, 2024 | 45.91 Mn |
| Mar 31, 2024 | 26.58 Mn |
| Dec 31, 2023 | 25.27 Mn |
| Sep 30, 2023 | 26.66 Mn |
| Jun 30, 2023 | 26.74 Mn |
| Mar 31, 2023 | 25.95 Mn |
| Dec 31, 2022 | 26.31 Mn |
| Sep 30, 2022 | 26.31 Mn |
| Jun 30, 2022 | 26.31 Mn |
| Mar 31, 2022 | 25.83 Mn |
| Dec 31, 2021 | 23.56 Mn |
| Mar 31, 2021 | 23.56 Mn |